Literature DB >> 27983856

Sodium Oleate-Based Nanoemulsion Enhances Oral Absorption of Chrysin through Inhibition of UGT-Mediated Metabolism.

Dong Dong1, Enxi Quan2, Xue Yuan2, Qian Xie2, Zhijie Li1, Baojian Wu2.   

Abstract

Oral bioavailability of flavonoids (and many phenolic drugs) is severely limited by extensive first-pass glucuronidation. Here we aimed to determine the modulatory effects of commonly used pharmaceutical excipients (PEs) on UDP-glucuronosyltransferase (UGT) activities and to evaluate the potential of nanoemulsions containing a UGT-inhibitory PE for oral absorption enhancement of chrysin, a model flavonoid. The effects of PEs on glucuronidation were determined using tissue (liver and intestine) microsomes, expressed UGT1A1 enzyme, and UGT1A1-overexpressing HeLa cells. Nanoemulsions were prepared using a modified emulsification technique and subsequently characterized by particle size, zeta-potential, morphology, and in vitro drug release. Pharmacokinetic studies were performed with rats to assess the effects of nanoemulsions on the metabolism and pharmacokinetics of chrysin. Of 21 PEs, five (i.e., Brij 35, Brij 58, labrasol, sodium oleate, and Tween 20) significantly inhibited chrysin glucuronidation. Of note, sodium oleate was the most potent inhibitor of glucuronidation. Eight PEs including Tween 80 had no effects on glucuronidation of chrysin. The chrysin nanoemulsions prepared with sodium oleate (named SO-NE) were spherical or near-spherical (particle size, 83.2 nm; zeta-potential, -43.7 mV; entrapment efficiency, 89.5%). The reference nanoemulsions prepared with Tween 80 (T80-NE) were highly similar to SO-NE in terms of particle size, zeta-potential, and drug release. It was demonstrated in pharmacokinetic studies that SO-NE led to a 4.3-fold increase in systemic exposure of chrysin and a 3.5-fold increase in Cmax value, whereas T80-NE did not cause any changes in chrysin pharmacokinetics. In conclusion, sodium oleate-based nanoemulsions greatly enhanced oral absorption of chrysin. Oral absorption enhancement of chrysin was attained through targeted inhibition of first-pass glucuronidation by sodium oleate.

Entities:  

Keywords:  UGTs; bioavailability; flavonoids; nanoemulsions; pharmaceutical excipients

Mesh:

Substances:

Year:  2016        PMID: 27983856     DOI: 10.1021/acs.molpharmaceut.6b00851

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  8 in total

1.  Enhanced bioavailability and hepatoprotective effect of silymarin by preparing silymarin-loaded solid dispersion formulation using freeze-drying method.

Authors:  Dong Yu Lim; Minyeong Pang; Jaehyeok Lee; Jihoon Lee; Ji-Hyeon Jeon; Jin-Hyang Park; Min-Koo Choi; Im-Sook Song
Journal:  Arch Pharm Res       Date:  2022-09-30       Impact factor: 6.010

2.  Improving Anticancer Activity of Chrysin using Tumor Microenvironment pH-Responsive and Self-Assembled Nanoparticles.

Authors:  Ashok Kumar Jangid; Raghu Solanki; Sunita Patel; Kanakaraju Medicherla; Deep Pooja; Hitesh Kulhari
Journal:  ACS Omega       Date:  2022-04-25

3.  Hydrous icaritin nanorods with excellent stability improves the in vitro and in vivo activity against breast cancer.

Authors:  Yian Wang; Tiantian Huang; Haowen Li; Jingxin Fu; Hui Ao; Likang Lu; Meihua Han; Yifei Guo; Feng Yue; Xiangtao Wang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 4.  Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders.

Authors:  Awanish Mishra; Pragya Shakti Mishra; Ritam Bandopadhyay; Navneet Khurana; Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  Molecules       Date:  2021-10-26       Impact factor: 4.411

Review 5.  Developing nutritional component chrysin as a therapeutic agent: Bioavailability and pharmacokinetics consideration, and ADME mechanisms.

Authors:  Song Gao; Nyma Siddiqui; Imoh Etim; Ting Du; Yun Zhang; Dong Liang
Journal:  Biomed Pharmacother       Date:  2021-08-24       Impact factor: 6.529

6.  Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions.

Authors:  Haowen Li; Manzhen Li; Jingxin Fu; Hui Ao; Weihua Wang; Xiangtao Wang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

7.  Systemic delivery of the anticancer agent arenobufagin using polymeric nanomicelles.

Authors:  Xue Yuan; Qian Xie; Keyu Su; Zhijie Li; Dong Dong; Baojian Wu
Journal:  Int J Nanomedicine       Date:  2017-07-12

Review 8.  The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update.

Authors:  Reem Abou Assi; Ibrahim M Abdulbaqi; Chan Siok Yee
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.